Histocompatibility testing is essential for donor identification and risk assessment in solid
organ and hematopoietic stem cell transplant. Additionally, it is useful for identifying donor …

Next-Generation Sequencing (NGS) has transformed clinical histocompatibility laboratories
through its capacity to provide accurate, high-throughput, high-resolution typing of Human …

Background Human leukocyte antigen matching at allelic resolution is proven clinically
significant in hematopoietic stem cell transplantation, lowering the risk of graft-versus-host …

High-resolution human leukocyte antigen (HLA) matching reduces graft-versus-host disease
and improves overall patient survival after hematopoietic stem cell transplant. Sanger …

Histocompatibility testing for stem cell and solid organ transplantation has become
increasingly complex as newly discovered HLA alleles are described. HLA typing …

Histocompatibility testing for stem cell and solid organ transplantation has become
increasingly complex as newly discovered human leukocyte antigen (HLA) alleles are …

Hematopoietic stem cell transplantation (HSCT) from HLA-matched donors significantly
decreases the risks of graft-rejection and graft-versus-host disease. Long-range PCR …

The Histocompatibility and Immunogenetics laboratories provide disease association and
pharmacogenetic analyses as well as the tests required for transplantation immunology and …

Human leucocyte antigen (HLA) genes play an important role in the success of organ
transplantation and are associated with autoimmune and infectious diseases. Current DNA …

Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative therapy for severe
blood diseases. According to the EBMT activity survey, unrelated stem cell donors provided …